Inventory of medical unicorn companies in the big health industry
On March 1, 2017, the Torch Center of the Ministry of Science and Technology and the Great Wall Enterprise Strategy Institute released the "2016 China Unicorn Enterprise Development Report" and the Unicorn Enterprise List in Beijing. Qingke Private Equity provided data for the report. stand by.
In 2016, there were 131 Chinese unicorn enterprises with a total valuation of 487.6 billion US dollars, distributed in 18 industry sectors and 16 cities. Among them, big health accounts for 7% of the unicorn general enterprise, accounting for 3.2% of the total valuation. The list is as follows:
Shanghai Fuhong Hanlin Biotechnology Co., Ltd.
Corporate Information
Legal representative: Fu Jiemin
Registered capital: 350 million yuan
Company type: Co., Ltd. (Sino-foreign joint venture, unlisted)
Date of establishment: 2010-02-24
Business address: Shanghai
Business scope: research and development of monoclonal antibody drugs
Financing information
product information
From the patent point of view, there should be anti-CTLA-4 human antibody.
This RT-PCR system is a necessary equipment for quantitative analysis of 2019-nCoV in big quantity during the COVID-19 pandemic, and this real-time PCR system can also be widely used in various fields such as scientific research, clinical detection and diagnosis, quality and safety testing, and forensic applications.
real time pcr equipment,real time pcr system,real time pcr device,real time pcr machine,rt pcr instrument
Shenzhen Uni-medica Technology Co.,Ltd , https://www.unimedicadevice.com